Point72 Asset Management »

Zenas Biopharma shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 403k 25.01
2024-09-30 $975k 58k 16.92

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
BlackRock
Vanguard Group
Novo A/S
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma